Supply chain
Work on a variety of initiatives that transform how insights are built for pharmacy trends, spend and fraud.
Department
What to expect
Provide analytical, reporting and technological support for areas including pharmacy audit and FWA, pharmacy network management, pharmacy trade relations and supply chain economics.
Preventing fraud, waste and abuse
Investigate claims, audit pharmacies and work with prescribers to prevent unlawful pharmacy activity.
Working together
Cross-functional partnership is core to being successful at mitigating fraud, waste and abuse.
Building new solutions
Build relationships across the health care landscape that will service our clients and accounts to the fullest.
Supply chain success profile
Presentation skills
Persuades, engages, informs an audience by clearly stating the message.
Program and
process
management
Use agile methodology to unfold new technology and enhance current work while managing day-to-day tasks.
Technology
knowledge
Use modern workspace technology to be effective in your job.
Agile experience
Think quickly and be mentally aware.
Data analysis &
management
Be Investigative, detail orientated in a structured environment.
Culture
What makes working at Prime unique?
We’re a purpose-driven, privately-held company that’s big enough to make a difference and small enough for you to have an impact.
Flexibility and generous PTO to promote a better work/life balance.
Growth, which offers more opportunities to advance your career.
A culture that promotes and cultivates diversity, equity and inclusion.
News
Your source for the latest Prime news, including product launches, company announcements, client success stories, and much more.
In the news
March 29, 2023
Adeno-Associated Virus Gene Therapies in the Pipeline, Barriers to Existing Drugs and Solutions | AMCP 2023
Managed Healthcare Executive
In the news
March 29, 2023
Magellan Team Discusses ‘Mortgage-like’ Payments For Ultra-Expensive Gene Therapies | AMCP 2023
Managed Healthcare Executive
In the news
March 27, 2023
Getting Ophthalmic Biosimilars to Market Continues to Prove Difficult
American Journal of Managed Care